SIEYUAN HKEX IPO Filing Lapses; Ranks Third among Domestic Private Enterprises in Power Transmission, Distribution and Control Equipment
NewTimeSpace News: The listing application submitted by Sieyuan Electric Co., Ltd. to the HKEX on 11 February 2026 has lapsed, as it has been pending for six months. CITIC SEC served as the original sole sponsor.
The Company is a global manufacturer of power transmission and distribution equipment and a provider of comprehensive power and energy solutions. With more than three decades of presence in the energy sector, it focuses on the R&D, design, manufacturing and sales of power transmission and distribution equipment and core components, spanning six core business lines: switchgear, transformers, protection and automation, power electronics, energy storage systems and components, and EPC, with products widely applied in diverse scenarios including power grids, new energy, metallurgy, petrochemicals, transportation and data centers.
According to Frost & Sullivan, by 2024 revenue in China's power transmission, distribution and control equipment market, the Company ranked eighth among international enterprises, fifth among domestic enterprises and third among domestic private enterprises, with a market share of 3.5%. By 2024 revenue in China's switchgear market, it ranked fourth among domestic enterprises and third among domestic private enterprises; in disconnectors, it ranked second among domestic enterprises and first among domestic private enterprises; and in instrument transformers, it ranked second among domestic enterprises and first among domestic private enterprises. As of 30 September 2025, its business has covered more than 100 countries and regions worldwide, with the share of overseas revenue continuing to rise.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
- AOM INT'L (00381.HK): Launches Twelve Dynasties Wine Project Combining Cultural Export and Digital Assets
- KINETIC DEV (01277.HK): Sierra Leone Rutile Project Commences Production
- CNE TECH CORP (00611.HK): Acquisition Consideration Adjusted Down to RMB71.93m